LDLRAD1 Activators
LDLRAD1 activators represent a distinct chemical class renowned for their capacity to modulate the activity of LDLRAD1, a protein encoded by the LDLRAD1 gene. LDLRAD1, also known as Low-density lipoprotein receptor class A domain-containing protein 1, plays a crucial role in cellular cholesterol metabolism and lipoprotein trafficking. This protein is a member of the low-density lipoprotein (LDL) receptor family and is involved in the endocytic uptake of LDL particles, contributing to the regulation of cholesterol levels within the cell. Activators targeting LDLRAD1 exert their effects by potentially enhancing its interaction with LDL particles, promoting its internalization, or modulating its intracellular trafficking pathways. These activators are integral for maintaining cholesterol homeostasis and ensuring proper cellular function.
Structurally, LDLRAD1 activators may exhibit diverse chemical architectures, reflecting the complexity required for effective engagement with the target protein. These molecules may possess specific binding motifs or functional groups that facilitate their interaction with LDLRAD1, allowing them to modulate its activity in a precise manner. Understanding the structural and biochemical properties of LDLRAD1 activators is crucial for unraveling the molecular mechanisms governing cellular cholesterol metabolism and lipoprotein trafficking. Further exploration of the pharmacological characteristics and biological significance of LDLRAD1 activators holds promise for advancing our understanding of lipid biology and may offer insights into novel strategies for modulating cholesterol levels and preventing dyslipidemia-related disorders in various biological contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Statins inhibit cholesterol synthesis, potentially upregulating LDLRAD1 as part of a compensatory mechanism to increase LDL uptake. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Fibrates activate PPARα, influencing lipid metabolism and potentially increasing LDLRAD1 expression to enhance lipid clearance. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Polyphenols can influence lipid metabolism and cardiovascular health, potentially affecting LDLRAD1 expression as part of their cardioprotective effects. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
As PPARγ agonists, thiazolidinediones influence lipid and glucose metabolism, potentially affecting LDLRAD1 expression. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Ezetimibe inhibits intestinal cholesterol absorption, potentially influencing LDLRAD1 expression as part of a compensatory response in cholesterol metabolism. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Catechins can modulate lipid metabolism, potentially inducing LDLRAD1 expression as part of their effect on reducing cholesterol levels. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences lipid metabolism and anti-inflammatory pathways, potentially affecting LDLRAD1 expression as part of its cardiovascular benefits. | ||||||
Allicin | 539-86-6 | sc-202449 sc-202449A | 1 mg 5 mg | $489.00 $1557.00 | 7 | |
Garlic and its components can affect cholesterol metabolism, potentially upregulating LDLRAD1 as part of their lipid-lowering effects. | ||||||